Clinical trial
A Phase 1/2 Study of ARRY-520 in Patients With Advanced Myeloid Leukemia
NCT00637052 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Study of ARRY-520 in Patients With Advanced Myeloid Leukemia
- Lead sponsor
- Pfizer
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 18, 2008
- Completion date
- June 21, 2010
- Enrollment
- 36 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia, advanced mds